Advertisement

Research Article Free access | 10.1172/JCI115974

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

J D Reveille, E Durban, M J MacLeod-St Clair, R Goldstein, R Moreda, R D Altman, and F C Arnett

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Reveille, J. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Durban, E. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by MacLeod-St Clair, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Goldstein, R. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Moreda, R. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Altman, R. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

Find articles by Arnett, F. in: JCI | PubMed | Google Scholar

Published September 1, 1992 - More info

Published in Volume 90, Issue 3 on September 1, 1992
J Clin Invest. 1992;90(3):973–980. https://doi.org/10.1172/JCI115974.
© 1992 The American Society for Clinical Investigation
Published September 1, 1992 - Version history
View PDF
Abstract

Previous studies in Caucasians with progressive systemic sclerosis (PSS) have suggested associations of antitopoisomerase I (antitopo I) autoantibodies with either serologically defined HLA-DR2 or DR5. To better define class II HLA associations with the antitopo I response, 161 PSS patients (132 Caucasians and 29 American blacks) were studied for antitopo I autoantibodies by immunodiffusion and immunoblotting, and their HLA-DRB1, DRB3, DQA1, and DQB1 alleles were determined by restriction fragment length polymorphic analysis and DNA oligotyping. Among Caucasians with antitopo I, HLA-DR5(DRB1*1101-*1104), DRB3*0202 and DQw3 (DQw7,8,9) were significantly increased in frequency. In American blacks, however, only HLA-DQB1*0301(DQw7) was significantly increased. The presence of HLA-DQB1*0301(DQw7) and other HLA-DQB1 alleles bearing the uncharged polar amino acid residue tyrosine at position 30 of the outermost domain was found in all antitopo I-positive Caucasian PSS patients compared with 66% of antitopo I-negative PSS patients (pc = 0.007) and 70% of normal controls (pc = 0.008), as well as all antitopo I-positive black patients. The association with HLA-DQB1 was independent of HLA-DR5(DRB1*1101-*1104) or any other HLA-DRB1, DRB3, or DQA1 alleles. Alternative or additional candidate epitopes for this autoimmune response include alanine at position 38 and threonine at position 77 of these same DQB1 alleles. These data suggest that genetic predisposition to the antitopo I response in PSS is associated most closely with the HLA-DQB1 locus.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (September 1, 1992): No description
Advertisement
Advertisement